Rheumatoid Arthritis Drug May Fight Severe COVID-19, Early Data Show
THURSDAY, July 23, 2020 (HealthDay News) — In a small study from France, an immune-dampening drug used by people battling rheumatoid arthritis showed promise in patients hospitalized with severe COVID-19. The drug, called anakinra, targets pro-inflammatory responses that kick into high gear in advanced COVID-19 — the so-called “cytokine storm.”Continue Reading